Novo Nordisk — Ransomware Incident Claimed by FulcrumSec

[AI generated] Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, it specializes in treatments for diabetes, obesity, hemophilia, and other chronic conditions. The company is a global leader in insulin production and develops drugs such as semaglutide. It operates in over 80 countries and is one of Europe's most valuable corporations by market capitalization.

Browse the incident tracker

Read the full analysis on IntelFusions